Du, Gang https://orcid.org/0000-0003-0805-4778
Healy, Liam B. https://orcid.org/0000-0002-2640-1596
David, Liron https://orcid.org/0000-0002-9750-543X
Walker, Caitlin https://orcid.org/0000-0003-0977-8276
El-Baba, Tarick J. https://orcid.org/0000-0003-4497-9938
Lutomski, Corinne A. https://orcid.org/0000-0001-7509-103X
Goh, Byoungsook https://orcid.org/0000-0002-7894-7259
Gu, Bowen https://orcid.org/0000-0003-2629-9963
Pi, Xiong https://orcid.org/0000-0001-8835-6914
Devant, Pascal https://orcid.org/0000-0001-9743-6764
Fontana, Pietro https://orcid.org/0000-0003-3215-3784
Dong, Ying
Ma, Xiyu
Miao, Rui
Balasubramanian, Arumugam https://orcid.org/0000-0002-7333-8542
Puthenveetil, Robbins
Banerjee, Anirban https://orcid.org/0000-0003-1494-6801
Luo, Hongbo R. https://orcid.org/0000-0002-8545-0451
Kagan, Jonathan C. https://orcid.org/0000-0003-2364-2746
Oh, Sungwhan F. https://orcid.org/0000-0002-0280-7903
Robinson, Carol V. https://orcid.org/0000-0001-7829-5505
Lieberman, Judy https://orcid.org/0000-0002-6200-4715
Article History
Received: 10 August 2023
Accepted: 2 April 2024
First Online: 10 April 2024
Competing interests
: H.W. and J.L. are cofounders of Ventus Therapeutics. J.C.K. consults and holds equity in Corner Therapeutics, Larkspur Biosciences, MindImmune Therapeutics and Neumora Therapeutics. None of these relationships impacted this study. The other authors declare no competing interests.